10476-0 |
Desmin Ag |
PrThr |
Tiss |
Pt |
Ord |
Immune stain |
|
ACTIVE |
Desmin Ag [Presence] in Tissue by Immune stain |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
10476-0 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
Desmin Ag Tiss Ql ImStn |
|
|
|
|
|
Antigen; Antigens; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified |
2.73 |
1.0i |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
104760-4 |
Cytomegalovirus DNA |
PrThr |
XXX |
Pt |
Ord |
Molgen |
|
ACTIVE |
Cytomegalovirus DNA [Presence] in Specimen by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
104760-4 |
|
Molgen |
|
|
Both |
|
|
|
0 |
CMV DNA Spec Ql |
|
|
|
N |
|
CMV; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; HHV-5; Human Herpesvirus-5; Microbiology; Misc; Miscellaneous; Molecular genetics; Ordinal; Other; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104761-2 |
Poikilocytosis |
PrThr |
Bld |
Pt |
Ord |
|
|
ACTIVE |
Poikilocytosis [Presence] in Blood |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
104761-2 |
|
|
|
|
Observation |
|
|
|
0 |
Poikilocytosis Bld Ql |
|
|
|
N |
|
Blood; HEMATOLOGY/CELL COUNTS; Ordinal; Poikilo; Poikilocyte; Poikilocytes; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104762-0 |
HIV 1 RNA |
LnCnc |
Ser/Plas |
Pt |
Qn |
Molgen |
|
ACTIVE |
HIV 1 RNA [Log #/volume] in Serum or Plasma by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
Log cells/mL |
|
|
|
|
|
|
MICRO |
|
104762-0 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
HIV1 RNA SerPl-Log# |
|
|
|
N |
|
AIDS; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; Log NCNC; Log#; Microbiology; Molecular genetics; PCR; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.78 |
2.78 |
|
|
|
|
|
|
|
{Log_cells}/mL |
|
|
|
0 |
104763-8 |
Medication dispense instructions |
Prid |
Medication |
Pt |
Nar |
|
|
ACTIVE |
Medication dispense instructions [Identifier] Medication Narrative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MEDS |
|
104763-8 |
|
|
|
|
Observation |
|
|
|
0 |
Med dispense instr |
|
|
|
N |
|
Identity or presence; Med; MEDS; Narrative; Point in time; Random; Report |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104764-6 |
Base excess |
SCnc |
Bld |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Base excess in Blood |
|
DEL |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
HEM/BC |
|
104764-6 |
|
|
|
|
Observation |
|
|
|
0 |
Deprecated Base excess Bld-sCnc |
|
|
|
N |
|
Base ex; BE; Blood; BSE; EXS; HEMATOLOGY/CELL COUNTS; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood |
2.79 |
2.78 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
104765-3 |
Neisseria gonorrhoeae DNA |
PrThr |
XXX |
Pt |
Ord |
Molgen |
|
ACTIVE |
Neisseria gonorrhoeae DNA [Presence] in Specimen by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
104765-3 |
|
Molgen |
|
|
Both |
|
|
|
0 |
N gonorrhoea DNA Spec Ql |
|
|
|
N |
|
Deoxyribonucleic acid; GC; Gono; Gonorrhea; Microbiology; Misc; Miscellaneous; Molecular genetics; N gonorrhoea; N gonorrhoeae; Ordinal; Other; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104766-1 |
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA |
PrThr |
Cvx |
Pt |
Ord |
Molgen |
|
ACTIVE |
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
104766-1 |
|
Molgen |
|
|
Both |
|
|
|
0 |
HPV I/H Risk 4 DNA Cvx Ql |
|
|
|
N |
|
Cervix; Deoxyribonucleic acid; Genital tract; Genital warts; HPV; HPV I/H Risk 4; HPV16; HPV16 and 18; HPV16+18; HPV16+18+H Risk 12; HPV16+18+HRisk12DNA; Human papillomavirus; Microbiology; Molecular genetics; Ordinal; Papilloma virus high risk; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104767-9 |
Salmonella sp |
ID |
Isolate |
Pt |
Nom |
Sequencing |
|
ACTIVE |
Salmonella sp [Identifier] in Isolate by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
104767-9 |
|
Sequencing |
|
|
Observation |
|
|
|
0 |
Salmonella Islt Seq |
|
|
|
N |
|
high-throughput sequencing; HTS; Ident; Identifier; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random; Sal; Salmonel; species; spp |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104768-7 |
NCBI BioProject identifier |
ID |
XXX |
Pt |
Nom |
|
|
ACTIVE |
NCBI BioProject identifier [Identifier] in Specimen |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
104768-7 |
|
|
|
|
Observation |
|
|
|
0 |
NCBI BioPro id Spec |
|
|
|
N |
|
Ident; Identifier; Microbiology; Misc; Miscellaneous; NCBI BioPro id; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104769-5 |
NCBI sequence read archive number |
ID |
XXX |
Pt |
Nom |
|
|
ACTIVE |
NCBI sequence read archive number in Specimen |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
104769-5 |
|
|
|
|
Observation |
|
|
|
0 |
NCBI seq read archive num Spec |
|
|
|
N |
|
Ident; Identifier; Microbiology; Misc; Miscellaneous; NCBI seq read archive num; No; Nominal; Num; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
10477-8 |
Enolase.neuron specific Ag |
PrThr |
Tiss |
Pt |
Ord |
Immune stain |
|
ACTIVE |
Enolase.neuron specific Ag [Presence] in Tissue by Immune stain |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
10477-8 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
NSE Ag Tiss Ql ImStn |
|
|
|
|
|
Antigen; Antigens; ENO2; enolase 2; Gamma-enolase; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; NSE; Ordinal; Pathology; Phosphopyruvate dehydratase; Phosphopyruvate hydratase.gamma subunit; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; St; Stains; Stn; Tissue; Tissue, unspecified; Tumor marker |
2.73 |
1.0i |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
104770-3 |
NCBI sequence read experiment (SRX) number |
ID |
XXX |
Pt |
Nom |
|
|
ACTIVE |
NCBI sequence read experiment (SRX) number in Specimen |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
104770-3 |
|
|
|
|
Observation |
|
|
|
0 |
NCBI seq read exp (SRX) num Spec |
|
|
|
N |
|
Ident; Identifier; Microbiology; Misc; Miscellaneous; NCBI seq read exp (SRX) num; No; Nominal; Num; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104771-1 |
NCBI sequence read Run (SRR) number |
ID |
XXX |
Pt |
Nom |
|
|
ACTIVE |
NCBI sequence read Run (SRR) number in Specimen |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
104771-1 |
|
|
|
|
Observation |
|
|
|
0 |
NCBI seq read Run (SRR) num Spec |
|
|
|
N |
|
Ident; Identifier; Microbiology; Misc; Miscellaneous; NCBI seq read Run (SRR) num; No; Nominal; Num; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104772-9 |
Salmonella sp serotype |
ID |
Isolate |
Pt |
Nom |
Sequencing |
|
ACTIVE |
Salmonella sp serotype [Identifier] in Isolate by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
104772-9 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
Salmonella Sertyp Islt Seq |
|
|
|
N |
|
high-throughput sequencing; HTS; Ident; Identifier; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random; Sal; Salmonel; Sertyp; species; spp |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104773-7 |
NCBI Sample Accession Number |
ID |
XXX |
Pt |
Nom |
|
|
ACTIVE |
NCBI Sample Accession Number in Specimen |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
104773-7 |
|
|
|
|
Observation |
|
|
|
0 |
NCBI Sample Acc Num Spec |
|
|
|
N |
|
Access num; Ident; Identifier; Microbiology; Misc; Miscellaneous; NCBI Sample Acc Num; No; Nominal; Num; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104774-5 |
Salmonella sp antigenic formula |
ID |
Isolate |
Pt |
Nom |
Sequencing |
|
ACTIVE |
Salmonella sp antigenic formula [Identifier] in Isolate by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
104774-5 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
Salmonella sp Ag form Islt Seq |
|
|
|
N |
|
high-throughput sequencing; HTS; Ident; Identifier; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random; Sal; Salmonel; Salmonella sp Ag form; species; spp |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104775-2 |
Medication total daily effective dose |
Dosage |
Medication |
Pt |
Qn |
|
|
ACTIVE |
Medication total daily effective dose [Dosage] Medication |
|
ADD |
DefinitionDescription |
|
|
mg |
|
|
|
|
|
|
MEDS |
|
104775-2 |
|
|
|
|
Observation |
|
|
|
0 |
Med total effect 24H dose Medication |
|
|
|
N |
|
Med; Med total effect 24H dose; MEDS; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl |
2.78 |
2.78 |
|
|
|
|
|
|
|
mg/(24.h) |
|
|
|
0 |
104776-0 |
Parainfluenza virus 2 RNA |
PrThr |
XXX |
Pt |
Ord |
Molgen |
|
ACTIVE |
Parainfluenza virus 2 RNA [Presence] in Specimen by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
104776-0 |
|
Molgen |
|
|
Both |
|
|
|
0 |
HPIV2 RNA Spec Ql |
|
|
|
N |
|
HPIV; HPIV2; Human rubulavirus 2; II; Microbiology; Misc; Miscellaneous; Molecular genetics; Ordinal; Other; Para; Parainflu; Parainfluenza type 2; Parainfluenza type II; PCR; PI2; Point in time; PR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; Spec; To be specified in another part of the message; Unspecified |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104777-8 |
Medication safety override reason |
Find |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Medication safety override reason |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MEDS |
|
104777-8 |
|
|
|
|
Observation |
|
|
|
0 |
Med safety override reason |
|
|
|
N |
|
Finding; Findings; Med safety override; Med safety override reason; MEDS; Nominal; Point in time; Random |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104778-6 |
Medication maximum dose |
Dosage |
Medication |
Pt |
Qn |
|
|
ACTIVE |
Medication maximum dose [Dosage] Medication |
|
ADD |
DefinitionDescription |
|
|
mg |
|
|
|
|
|
|
MEDS |
|
104778-6 |
|
|
|
|
Observation |
|
|
|
0 |
Med max dose Medication |
|
|
|
N |
|
Med; Med max dose; MEDS; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.78 |
2.78 |
|
|
|
|
|
|
|
mg |
|
|
|
0 |
104779-4 |
Schistocytes |
PrThr |
Bld |
Pt |
Ord |
|
|
ACTIVE |
Schistocytes [Presence] in Blood |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
104779-4 |
|
|
|
|
Both |
|
|
|
0 |
Schistocytes Bld Ql |
|
|
|
N |
|
Blood; Fragmented cells; HEMATOLOGY/CELL COUNTS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Schisto; Schistocyte; Screen; WB; Whole blood |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
10478-6 |
Eosinophil major basic protein Ag |
PrThr |
Tiss |
Pt |
Ord |
Immune stain |
|
ACTIVE |
Eosinophil major basic protein Ag [Presence] in Tissue by Immune stain |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
10478-6 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
EMBP Ag Tiss Ql ImStn |
|
|
|
|
|
Antigen; Antigens; EMBP; Eos; Eosin; Eosino; Eosinophils; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; PRG2; Prot; Proteoglycan 2; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified |
2.56 |
1.0i |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
104780-2 |
Neisseria gonorrhoeae rRNA |
PrThr |
XXX |
Pt |
Ord |
Molgen |
|
ACTIVE |
Neisseria gonorrhoeae rRNA [Presence] in Specimen by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
104780-2 |
|
Molgen |
|
|
Both |
|
|
|
0 |
N gonorrhoea rRNA Spec Ql |
|
|
|
N |
|
GC; Gono; Gonorrhea; Microbiology; Misc; Miscellaneous; Molecular genetics; N gonorrhoea; N gonorrhoeae; Ordinal; Other; PCR; Point in time; PR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; Spec; To be specified in another part of the message; Unspecified |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
104781-0 |
HIV 1 RNA |
NCnc |
Ser/Plas |
Pt |
Qn |
Molgen |
|
ACTIVE |
HIV 1 RNA [#/volume] in Serum or Plasma by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
/vol |
|
|
|
|
|
|
MICRO |
|
104781-0 |
|
Molgen |
|
|
Both |
|
|
|
0 |
HIV1 RNA # SerPl |
|
|
|
N |
|
#; ABS; absolute; absolutes; AIDS; Cnt; Count; Count/volume; CT; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; Microbiology; Molecular genetics; Number concentration; Number Concentration (count/vol); PCR; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.78 |
2.78 |
|
|
|
|
|
|
|
/{vol} |
|
|
|
0 |